News Does the Novavax delay augur a COVID vaccine policy change? Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.
Patients Protecting the immunocompromised: Preventative measures agai... COVID-19 vaccines are not as effective in immunocompromised individuals as they are in the general population, due to an inability to produce a robust protective response to the vaccine.
Views & Analysis Not just COVID-19 vaccines: 5 things that cause blood clots Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.